Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 3.30%52.13B | 10.52%207.17B | 10.92%50.46B | -1.90%187.46B | 6.60%52.72B | -0.17%46.3B | -3.78%42.95B | -10.11%45.5B | -0.09%191.08B | -8.18%49.45B |
| Cost of revenue | 3.10%38.2B | 10.35%155.5B | 9.63%37.05B | -5.25%140.92B | 5.81%40.26B | -4.77%34.66B | -7.16%32.2B | -14.66%33.8B | -1.53%148.73B | -12.56%38.05B |
| Gross profit | 3.86%13.93B | 11.03%51.68B | 14.68%13.42B | 9.90%46.54B | 9.24%12.46B | 16.59%11.64B | 7.98%10.74B | 6.25%11.7B | 5.32%42.35B | 10.22%11.4B |
| Operating expense | 9.15%8.11B | 10.05%32.3B | 7.28%7.43B | 4.70%29.35B | 8.91%8.35B | 7.28%7.14B | 1.82%6.94B | 0.38%6.92B | 4.69%28.03B | 5.13%7.66B |
| Operating profit | -2.71%5.83B | 12.71%19.38B | 25.40%5.99B | 20.08%17.19B | 9.92%4.11B | 35.22%4.5B | 21.36%3.81B | 16.10%4.78B | 6.57%14.32B | 22.34%3.74B |
| Net non-operating interest income (expenses) | 3.07%168M | 110.08%771M | 103.75%163M | 1,123.33%367M | 488.00%147M | 833.33%66M | 94.74%74M | 433.33%80M | 600.00%30M | 292.31%25M |
| Non-operating interest income | -6.92%242M | 69.50%1.1B | 162.63%260M | 471.68%646M | 376.47%243M | 747.37%161M | 376.67%143M | 661.54%99M | 101.79%113M | 1,175.00%51M |
| Non-operating interest expense | -23.71%74M | 16.13%324M | 410.53%97M | 236.14%279M | 269.23%96M | 239.29%95M | 962.50%69M | -48.65%19M | 33.87%83M | 52.94%26M |
| Net investment income | 148.13%77M | 79.77%-87M | -25.00%-160M | 42.20%-430M | -52.51%-334M | 143.79%141M | -1,008.33%-109M | 40.47%-128M | -565.00%-744M | -895.45%-219M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 0 | -143.53%-37M | 2M | -69.53%85M | -116.00%-54M | 0 | 1,000.00%279M | 73.96%-25M | ||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 300.00%4M | -152.85%-311M | 200.00%1M | -192.86%-123M | -141.67%-116M | -550.00%-9M | 50.00%3M | -150.00%-1M | 61.82%-42M | -4.35%-48M |
| Less:Restructuring and mergern&acquisition | 0.00%-4M | 0.00%-18M | 0.00%-4M | 0.00%-18M | 0.00%-5M | 0.00%-4M | 0.00%-5M | 0.00%-4M | 0.00%-18M | 0.00%-5M |
| Less:Other special charges | ---- | 27.54%88M | -40.00%3M | 392.86%69M | 600.00%49M | 550.00%13M | -33.33%2M | 150.00%5M | -68.18%14M | -69.57%7M |
| Less:Write off | ---- | 234.72%241M | ---- | 56.52%72M | ---- | ---- | ---- | ---- | -45.24%46M | ---- |
| Other non-operating income (expenses) | -200.00%-2M | -247.06%-25M | 2M | -37.04%17M | -4,000.00%-41M | 62.50%13M | -57.81%27M | -106.25%-1M | ||
| Income before tax | 1.30%6.07B | 15.10%19.69B | 26.87%6B | 23.35%17.11B | 6.94%3.71B | 56.45%4.71B | 12.67%3.96B | 22.02%4.73B | 2.63%13.87B | 19.90%3.47B |
| Income tax | 10.85%1.87B | 17.24%5.61B | 29.00%1.69B | 15.63%4.79B | 0.35%1.13B | 43.10%1.26B | 8.46%1.09B | 15.97%1.31B | -1.52%4.14B | 9.82%1.13B |
| Net income | -2.44%4.21B | 14.26%14.08B | 26.10%4.31B | 26.63%12.32B | 10.17%2.58B | 61.86%3.45B | 14.40%2.87B | 24.47%3.42B | 4.52%9.73B | 25.46%2.34B |
| Net income continuous operations | -2.44%4.21B | 14.26%14.08B | 26.06%4.31B | 26.63%12.32B | 10.12%2.58B | 61.93%3.45B | 14.35%2.87B | 24.51%3.42B | 4.51%9.73B | 25.46%2.34B |
| Noncontrolling interests | -66.67%2M | -80.83%23M | -84.21%6M | -3.23%120M | -43.48%13M | 26.32%48M | -54.35%21M | 123.53%38M | 416.67%124M | 475.00%23M |
| Net income attributable to the company | -2.35%4.2B | 15.19%14.05B | 27.35%4.3B | 27.03%12.2B | 10.74%2.57B | 62.53%3.41B | 15.73%2.85B | 23.82%3.38B | 3.45%9.6B | 24.49%2.32B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -2.35%4.2B | 15.19%14.05B | 27.35%4.3B | 27.03%12.2B | 10.74%2.57B | 62.53%3.41B | 15.73%2.85B | 23.82%3.38B | 3.45%9.6B | 24.49%2.32B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -1.28%43.24 | 15.23%143.07 | 27.33%43.8 | 26.97%124.16 | 10.72%26.12 | 62.57%34.66 | 15.64%28.98 | 23.65%34.4 | 3.34%97.79 | 24.29%23.59 |
| Diluted earnings per share | -1.28%43.24 | 15.23%143.07 | 27.33%43.8 | 26.97%124.16 | 10.72%26.12 | 62.54%34.6533 | 15.64%28.98 | 23.65%34.4 | 3.34%97.79 | 24.29%23.59 |
| Dividend per share | 0 | 16.22%43 | 0 | 12.12%37 | 12.12%37 | 0 | 0 | 0 | 3.13%33 | 3.13%33 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |